Last week, the Centre restricted the export of several active pharmaceutical ingredients (API) and formulations made from those ingredients.
In a laudable move, the Pharmaceuticals Export Promotion Council (Pharmexcil) came up with clarifications for its members and representations to the government highlighting some difficulties. Two weeks ago, the finance minister met several business leaders to get their inputs regarding the disruptions caused by the outbreak of coronavirus in many parts of the world. The pharmaceutical manufacturers said that, besides other problems, almost 70 per cent of the API required for making formulations are imported from China. Disruptions of those supplies will
Disclaimer: These are personal views of the writer. They do not necessarily reflect the opinion of www.business-standard.com or the Business Standard newspaper